Critics often claim that GLP-1 agonists (like semaglutide and tirzepatide) only provide temporary weight loss, arguing that patients regain weight after stopping the medication.

GLP-1 agonists (like semaglutide and tirzepatide) are widely known for their metabolic benefits, such as weight loss and blood sugar regulation. However, their impact on mental well-being and spiritual growth is often overlooked.

Explore how the FDA ruling on compounded GLP-1 drugs like semaglutide affects accessibility, insurance coverage, and what you can do next.

Everyone wants to lose weight, but not everyone wants to face... needles.